Skip to main content
Displaying 25 - 36 of 43
Display:
12
24
48
Metabolism, Alcohol & Toxicity
6
Boehringer Ingelheim: MASH in focus: novel insights on diagnosis, management and coordinated patient care - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
8
Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
8
Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
8
Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
8
Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
8
Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
8
Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
8
Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
8
Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024
View
Viral Hepatitis
6
AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024
View
Viral Hepatitis
6
AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024
View
Viral Hepatitis
6
AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Page
2
Current page
3
Page
4
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy